Panic disorder is associated with the Val308Iso polymorphism in the hypocretin receptor gene

Psychiatric Genetics

Volumn 21, Issue 2, 2011, Pages 85-89

  Annerbrink, Kristina ^a   Westberg, Lars ^a   Olsson, Marie ^b   Andersch, Sven ^a   Sjödin, Ingemar ^c   Holm, Göran ^b   Allgulander, Christer ^d   Eriksson, Elias ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c LINKÖPING UNIVERSITY   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

association study; orexin hypocretin; panic disorder; polymorphism

Indexed keywords

OREXIN 1 RECEPTOR; OREXIN 2 RECEPTOR;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE REPLICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; PANIC; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AMINO ACID SUBSTITUTION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; PANIC DISORDER; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE;

EID: 79952656228     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/YPG.0b013e328341a3db     Document Type: Article

References (65)

1. Abelson JL, Nesse RM, Weg JG, Curtis GC (1996). Respiratory psychophysiology and anxiety: cognitive intervention in the doxapram model of panic. Psychosom Med 58:302-313. (Pubitemid 26250588)
2. Abelson JL, Weg JG, Nesse RM, Curtis GC (2001). Persistent respiratory irregularity in patients with panic disorder. Biol Psychiatry 49:588-595. (Pubitemid 32289353)
3. Adamantidis A, De Lecea L (2008). Physiological arousal: a role for hypothalamic systems. Cell Mol Life Sci 65:1475-1488.
4. Ahmadian A, Ehn M, Hober S (2006). Pyrosequencing: history, biochemistry and future. Clin Chim Acta 363:83-94. (Pubitemid 41748205)
5. Atlas SA (2007). The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition. J Manag Care Pharm 13:9-20.
6. Bandelow B, Saleh K, Pauls J, Domschke K, Wedekind D, Falkai P (2007). Insertion/deletion polymorphism in the gene for angiotensin converting enzyme (ACE) in panic disorder: a gender-specific effect? World J Biol Psychiatry 10:1-5.
7. Behan M, Zabka AG, Thomas CF, Mitchell GS (2003). Sex steroid hormones and the neural control of breathing. Respir Physiol Neurobiol 136:249-263. (Pubitemid 36809011)
8. Berthoud HR, Patterson LM, Sutton GM, Morrison C, Zheng H (2005). Orexin inputs to caudal raphe neurons involved in thermal, cardiovascular, and gastrointestinal regulation. Histochem Cell Biol 123:147-156. (Pubitemid 40674687)
9. Carlbring P, Gustagsson H, Ekselius L, Andersson G (2002). 12-month prevalence of panic disorder with or without agoraphobia in the Swedish general population. Soc Psychiatry Psychiatr Epidemiol 37:207-211. (Pubitemid 36067953)
10. Ciarka A, Vincent JL, Van De Borne P (2007). The effects of dopamine on the respiratory system: friend or foe? Pulm Pharmacol Ther 20:607-615.
11. de Lecea L, Kilduff TS, Peyron C, Gao X, Foye PE, Danielson PE, et al. (1988). The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 95:322-327.
12. Domschke K, Deckert J, O'Donovan MC, Glatt SJ (2007). Meta-analysis of COMT val158met in panic disorder: ethnic heterogeneity and gender specificity. Am J Med Genet B Neuropsychiatr Genet 144B:667-673. (Pubitemid 47077152)
13. Easton A, Dwyer E, Pfaff DW (2006). Estradiol and orexin-2 saporin actions on multiple forms of behavioral arousal in female mice. Behav Neurosci 120:1-9. (Pubitemid 43345101)
14. Elias CF, Saper CB, Maratos-Flier E, Tritos NA, Lee C, Kelly J, et al. (1998). Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J Comp Neurol 402:442-459. (Pubitemid 29001074)
15. Fukunaka Y, Shinkai T, Hwang R, Hori H, Utsunomiya K, Sakata S, et al. (2007). The orexin 1 receptor (HCRTR1) gene as a susceptibility gene contributing to polydipsia-hyponatremia in schizophrenia. Neuromolecular Med 9:292-297. (Pubitemid 350242632)
16. Fung SJ, Yamuy J, Sampogna S, Morales FR, Chase MH (2001). Hypocretin (orexin) input to trigeminal and hypoglossal motoneurons in the cat: a double-labeling immunohistochemical study. Brain Res 903:257-262. (Pubitemid 32904632)
17. Gorman JM, Askanazi J, Liebowitz MR, Fyer AJ, Stein J, Kinney JM, Klein DF (1984). Response to hyperventilation in a group of patients with panic disorder. Am J Psychiatry 141:857-861. (Pubitemid 14078996)
18. Gorman JM, Fyer MR, Goetz R, Askanazi J, Liebowitz MR, Fyer AJ, et al. (1988). Ventilatory physiology of patients with panic disorder. Arch Gen Psychiatry 45:31-39. (Pubitemid 18018567)
19. Hettema JM, Neale MC, Kendler KS (2001). A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 158:1568-1578. (Pubitemid 32923644)
20. Ho HP, Westberg L, Annerbrink K, Olsson M, Melke J, Nilsson S, et al. (2004). Association between a functional polymorphism in the progesterone receptor gene and panic disorder in women. Psychoneuroendocrinology 29:1138-1141. (Pubitemid 38829175)
21. Jennings DB (1994). The physicochemistry of [H +] and respiratory control: roles of PCO2, strong ions, and their hormonal regulators. Can J Physiol Pharmacol 72:1499-1512.
22. Jensen D, Webb KA, O'Donnell DE (2007). Chemical and mechanical adaptations of the respiratory system at rest and during exercise in human pregnancy. Appl Physiol Nutr Metab 32:1239-1250.
23. Johnson PL, Fitz SD, Hollis JH, Moratalla R, Lightman SL, Shekhar A, Lowry CA (2010a). Induction of c-Fos in 'panic/defence'-related brain circuits following brief hypercarbic gas exposure. J Psychopharmacol. [Epub ahead of print]
24. Johnson PL, Truitt W, Fitz SD, Minick PE, Dietrich A, Sanghani S, et al. (2010b). A key role for orexin in panic anxiety. Nat Med 16:111-115.
25. Johren O, Neidert SJ, Kummer M, Dendorfer A, Dominiak P (2001). Prepro-orexin and orexin receptor mRNAs are differentially expressed in peripheral tissues of male and female rats. Endocrinology 142:3324-3331. (Pubitemid 32681736)
26. Johren O, Neidert SJ, Kummer M, Dominiak P (2002). Sexually dimorphic expression of prepro-orexin mRNA in the rat hypothalamus. Peptides 23:1177-1180. (Pubitemid 34786309)
27. Johren O, Bruggemann N, Dendorfer A, Dominiak P (2003). Gonadal steroids differentially regulate the messenger ribonucleic acid expression of pituitary orexin type 1 receptors and adrenal orexin type 2 receptors. Endocrinology 144:1219-1225. (Pubitemid 36428462)
28. Kayaba Y, Nakamura A, Kasuya Y, Ohuchi T, Yanagisawa M, Komuro I, et al. (2003). Attenuated defense response and low basal blood pressure in orexin knockout mice. Am J Physiol Regul Integr Comp Physiol 285:R581-R593. (Pubitemid 37040566)
29. Kent JM, Papp LA, Martinez JM, Browne ST, Coplan JD, Klein DF, Gorman JM (2001). Specificity of panic response to CO(2) inhalation in panic disorder: a comparison with major depression and premenstrual dysphoric disorder. Am J Psychiatry 158:58-67. (Pubitemid 32047247)
30. Kinkead R, Bach KB, Johnson SM, Hodgeman BA, Mitchell GS (2001). Plasticity in respiratory motor control: intermittent hypoxia and hypercapnia activate opposing serotonergic and noradrenergic modulatory systems. Comp Biochem Physiol A Mol Integr Physiol 130:207-218. (Pubitemid 32822859)
31. Klein DF (1993). False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis. Arch Gen Psychiatry 50:306-317.
32. Kuwaki T (2008). Orexinergic modulation of breathing across vigilance states. Respir Physiol Neurobiol 164:204-212.
33. Lee YJ, Curtis GC,Weg JG, Abelson JL, Modell JG, Campbell KM (1993). Panic attacks induced by doxapram. Biol Psychiatry 33:295-297. (Pubitemid 23091508)
34. Liebowitz MR, Fyer AJ, Gorman JM, Dillon D, Appleby IL, Levy G, et al. (1984). Lactate provocation of panic attacks. I. Clinical and behavioral findings. Arch Gen Psychiatry 41:764-770.
35. Martinez JM, Kent JM, Coplan JD, Browne ST, Papp LA, Sullivan GM, et al. (2001). Respiratory variability in panic disorder. Depress Anxiety 14:232-237. (Pubitemid 34013795)
36. Meerabux J, Iwayama Y, Sakurai T, Ohba H, Toyota T, Yamada K, et al. (2005). Association of an orexin 1 receptor 408Val variant with polydipsiahyponatremia in schizophrenic subjects. Biol Psychiatry 58:401-407. (Pubitemid 41219708)
37. Mo Q, Lu S, Garippa C, Brownstein MJ, Simon NG (2009). Genome-wide analysis of DHEA- and DHT-induced gene expression in mouse hypothalamus and hippocampus. J Steroid Biochem Mol Biol 114:135-143.
38. Molosh AI, Johnson PL, Fitz SD, Dimicco JA, Herman JP, Shekhar A (2010). Changes in central sodium and not osmolarity or lactate induce panic-like responses in a model of panic disorder. Neuropsychopharmacology 35:1333-1347.
39. Nambu T, Sakurai T, Mizukami K, Hosoya Y, Yanagisawa M, Goto K (1999). Distribution of orexin neurons in the adult rat brain. Brain Res 827:243-260. (Pubitemid 29222929)
40. Ohno K, Sakurai T (2008). Orexin neuronal circuitry: role in the regulation of sleep and wakefulness. Front Neuroendocrinol 29:70-87.
41. Olsson M, Annerbrink K, Hedner J, Eriksson E (2004a). Intracerebroventricular administration of the angiotensin II receptor antagonist saralasin reduces respiratory rate and tidal volume variability in freely moving Wistar rats. Psychoneuroendocrinology 29:107-112. (Pubitemid 37298017)
42. Olsson M, Annerbrink K, Westberg L, Melke J, Baghaei F, Rosmond R, et al. (2004b). Angiotensin-related genes in patients with panic disorder. Am J Med Genet B Neuropsychiatr Genet 127B:81-84. (Pubitemid 38542319)
43. Papp LA, Klein DF, Gorman JM (1993). Carbon dioxide hypersensitivity, hyperventilation, and panic disorder. Am J Psychiatry 150:1149-1157. (Pubitemid 23218893)
44. Papp LA, Martinez JM, Klein DF, Coplan JD, Norman RG, Cole R, et al. (1997). Respiratory psychophysiology of panic disorder: three respiratory challenges in 98 subjects. Am J Psychiatry 154:1557-1565. (Pubitemid 27471349)
45. Perna G, Battaglia M, Garberi A, Arancio C, Bertani A, Bellodi L (1994). Carbon dioxide/oxygen challenge test in panic disorder. Psychiatry Res 52:159-171. (Pubitemid 24173290)
46. Peyron C, Tighe DK, Van Den Pol AN, De Lecea L, Heller HC, Sutcliffe JG, Kilduff TS (1998). Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18:9996-10015. (Pubitemid 28543775)
47. Pitts FN Jr, Mcclure JN Jr (1967). Lactate metabolism in anxiety neurosis. N Engl J Med 277:1329-1336.
48. Porka-Heiskanen T, Kalinchuck A, Alanko L, Huhtaniemi I, Stenberg D (2004). Orexin A and B levels in the hypothalamus of female rats: the effects of the estrous cycle and age. Eur J Endocrinol 150:737-742. (Pubitemid 38786547)
49. Rainero I, Rubino E, Valfre W, Gallone S, De Martino P, Zampella E, Pinessi L (2007). Association between the G1246A polymorphism of the hypocretin receptor 2 gene and cluster headache: a meta-analysis. J Headache Pain 8:152-156. (Pubitemid 47062586)
50. Rainero I, Gallone S, Rubino E, Ponzo P, Valfre W, Binello E, et al. (2008). Haplotype analysis confirms the association between the HCRTR2 gene and cluster headache. Headache 48:1108-1114. (Pubitemid 351952077)
51. Rosmond R, Bjorntorp P (1998). Psychiatric ill-health of women and its relationship to obesity and body fat distribution. Obes Res 6:338-345. (Pubitemid 128679681)
52. Rosmond R, Dallman MF, Bjorntorp P (1998). Stress-related cortisol secretion in men: relationships with abdominal obesity and endocrine, metabolic and hemodynamic abnormalities. J Clin Endocrinol Metab 83:1853-1859. (Pubitemid 28496305)
53. Sakurai T (2007). The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci 8:171-181.
54. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, et al. (1998). Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92:1-696.
55. Schurks M, Kurth T, Geissler I, Tessmann G, Diener HC, Rosskopf D (2006). Cluster headache is associated with the G1246A polymorphism in the hypocretin receptor 2 gene. Neurology 66:1917-1919. (Pubitemid 44049827)
56. Shekhar A, Johnson PL, Sajdyk TJ, Fitz SD, Keim SR, Kelley PE, et al. (2006). Angiotensin-II is a putative neurotransmitter in lactate-induced panic-like responses in rats with disruption of GABAergic inhibition in the dorsomedial hypothalamus. J Neurosci 26:9205-9215. (Pubitemid 44359847)
57. Silveyra P, Cataldi NI, Lux-Lantos V, Libertun C (2009). Gonadal steroids modulated hypocretin/orexin type-1 receptor expression in a brain region, sex and daytime specific manner. Regul Pept 158:121-126.
58. Stein MB, Millar TW, Larsen DK, Kryger MH (1995). Irregular breathing during sleep in patients with panic disorder. Am J Psychiatry 152:1168-1173.
59. Suzuki M, Beuckmann CT, Shikata K, Ogura H, Sawai T (2005). Orexin-A (hypocretin-1) is possibly involved in generation of anxiety-like behavior. Brain Res 1044:116-121. (Pubitemid 40616058)
60. Van den Boom D, Ehrich M (2007). Discovery and identification of sequence polymorphisms and mutations with MALDI-TOF MS. Methods Mol Biol 366:287-306.
61. Wilhelm FH, Trabert W, Roth WT (2001). Physiologic instability in panic disorder and generalized anxiety disorder. Biol Psychiatry 49:596-605. (Pubitemid 32289354)
62. Williams RH, Burdakov D (2008). Hypothalamic orexins/hypocretins as regulators of breathing. Expert Rev Mol Med 10:e28.
63. Young JK, Wu M, Manaye KF, Prabha KC, Allard JS, Mack SO, Haxhiu MA (2005). Orexin stimulates breathing via medullary and spinal pathways. J Appl Physiol 98:1387-1395. (Pubitemid 40396515)
64. Zhang W, Fukuda Y, Kuwaki T (2005). Respiratory and cardiovascular actions of orexin-A in mice. Neurosci Lett 385:131-136. (Pubitemid 40961649)
65. Zhang W, Shimoyama M, Fukuda Y, Kuwaki T (2006). Multiple components of the defense response depend on orexin: evidence from orexin knockout mice and orexin neuron-ablated mice. Auton Neurosci 126-127:139-145. (Pubitemid 43816930)